Cost Effectiveness Analysis Of The Use Of Human Fibrinogen (Clottafact®) In Masive Post-Partum Hemorragea In Mexico

Abstract

screening may reduce the annual number of stillbirths by up to 2,900, neonatal deaths by up to 1,100, the annual incidence of congenital syphilis by up to 1,450 and avert up to 130,000 DALYs at an incremental annual direct medical cost of US$ 5.9 million. The three relatively high prevalence countries of Brazil, Colombia and Haiti, account for over half of the total DALYs that could potentially be averted, whereas Chile and Cuba have already adopted universal screening. ConClusions: Use of ICS tests for antenatal syphilis screening is highly cost-effective in low and middle income countries in Latin America. Antenatal programs should either expand access or maintain full access to syphilis screening using the ICS test.